4D Molecular Therapeutics, Inc. (NASDAQ: FDMT)
$8.1400
-0.0600 ( -0.73% ) 42.2K
4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-125, 4D-110, and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector) 4D-310.
Market Data
Open
$8.1400
Previous close
$8.2000
Volume
42.2K
Market cap
$426.15M
Day range
$8.0600 - $8.4100
52 week range
$7.9000 - $36.2500
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 8-k | 8K-related | 13 | Sep 18, 2024 |
| 4 | Insider transactions | 1 | Sep 18, 2024 |
| 4 | Insider transactions | 1 | Aug 21, 2024 |
| 8-k | 8K-related | 13 | Aug 08, 2024 |
| 10-q | Quarterly Reports | 90 | Aug 08, 2024 |
| 3 | Insider transactions | 1 | Aug 01, 2024 |
| 8-k | 8K-related | 13 | Jul 23, 2024 |
| 4 | Insider transactions | 1 | Jul 18, 2024 |
| 8-k | 8K-related | 13 | Jul 17, 2024 |
| 4 | Insider transactions | 1 | Jul 15, 2024 |